Number of Subjects

Placebo

344

1216

755

IPTi-SP

344

1197

748

Episodes of Clinical Malaria

Placebo

166

826

336

IPTi-SP

146

854

344

% PE

14

−5

−16

95 CI (%)

(−11,33)

(−22, 9)

(−51, 11)

p-value

0.25

0.49

0.29

Episodes of Hospitalization with Malaria Parasites

Placebo

34

54

58

IPTi-SP

30

52

74

% PE

12

2

−39

95 CI (%)

(−45, 47)

(−57, 39)

(−130, 15)

p-value

0.61

0.94

0.19

Episodes of All-Cause Hospital Admissions

Placebo

108

203

205

IPTi-SP

111

224

202

% PE

−1

−12

4

95 CI (%)

(−38, 25)

(−43, 11)

(−34, 32)

p-value

0.94

0.34

0.79

Subjects with Anemia

Placebo

40

102

64

IPTi-SP

35

117

61

% PE

12

−17

4

95 CI (%)

(−34, 43)

(−59, 15)

(−35, 31)

p-value

0.54

0.34

0.82